Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves-Reference-Cited by-同舟云学术

Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

Published:1994-12 Issue:6 Part 1 Volume:152 Page:2037-2042
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Catalona William J.¹²³⁴⁵,Hudson M’Liss A.¹²³⁴⁵,Scardino Peter T.¹²³⁴⁵,Richie Jerome P.¹²³⁴⁵,Ahmann Frederick R.¹²³⁴⁵,Flanigan Robert C.¹²³⁴⁵,deKernion Jean B.¹²³⁴⁵,Ratliff Timothy L.¹²³⁴⁵,Kavoussi Louis R.¹²³⁴⁵,Dalkin Bruce L.¹²³⁴⁵,Waters W. Bedford¹²³⁴⁵,MacFarlane Michael T.¹²³⁴⁵,Southwick Paula C.¹²³⁴⁵

Affiliation:

1. From the Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri

2. Scott Department of Urology, Baylor College of Medicine, Houston, Texas

3. Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

4. Divisions of Urology and Hematology-Oncology, University of Arizona College of Medicine and Tucson Veterans Affairs Medical Center, Tucson, Arizona

5. Department of Urology, Loyola University Medical Center, Chicago, Illinois

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference22 articles.

1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;New Engl. J. Med.,1991

2. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen;Cooner;J. Urol.,1990

3. Screening for prostatic carcinoma with prostate specific antigen;Brawer;J. Urol.,1992

4. Prostate cancer screening: current trends and future implications;Littrup;CA,1992

5. Serum prostate specific antigen as pre-screening test for prostate cancer;Labrie;J. Urol.,1992

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Circulating miR-107 as a Potential Biomarker Up-Regulated in Castration-Resistant Prostate Cancer;Non-Coding RNA;2024-08-24

2. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia;Journal of Ethnopharmacology;2024-08

3. Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays;European Urology Open Science;2024-05

4. Construction and verification of a prostate cancer risk prediction model based on traditional screening methods;2024-01-22

5. Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA);Annales de Biologie Clinique;2023-02